Facial miliary osteoma in HIV patient

Camozzato, Camila; Basso, Franciani de Oliveira; Duquia, Rodrigo Pereira; Boff, Ana Letícia; Almeida, Hiram Larangeira de

doi:10.1590/s0365-05962011000700016

Cited by 4 publications

(1 citation statement)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Topical retinoids (0.025-0.1%) have been reported to be effective by some authors [19,21,25,26], particularly for the treatment of smaller, superficial lesions [4]. Other reports indicate less satisfactory results [3,5,7,9,65].…”

Section: Treatment Topical and Systemic Treatmentmentioning

confidence: 99%

Multiple miliary osteoma cutis: a comprehensive review and update of the literature

Duarte¹,

Pinheiro²,

Cabete³

2018

European Journal of Dermatology

View full text Add to dashboard Cite

Multiple miliary osteoma cutis consists of heterotopic foci of bone tissue in the dermis and subcutaneous tissue. Patients usually present with multiple, asymptomatic facial papules of several millimetres in diameter which cause distress regarding their cosmetic appearance. The condition is described as rare, as only a few cases have been reported since its first description in 1864 by Virchow. We therefore carried out a comprehensive literature search and review, in which 102 published cases were retrieved and analysed. The demographic and clinical aspects, as well as current therapy solutions, of this probably overlooked condition are discussed.

show abstract

Section: Treatment Topical and Systemic Treatmentmentioning

confidence: 99%

Multiple miliary osteoma cutis: a comprehensive review and update of the literature

Duarte¹,

Pinheiro²,

Cabete³

2018

European Journal of Dermatology

View full text Add to dashboard Cite

show abstract

HIVand the Skin

Bunker

Piguet

2016

Rook's Textbook of Dermatology, Ninth Edition

View full text Add to dashboard Cite

Acquired immune deficiency syndrome (AIDS) has been recognized, and human immunodeficiency virus (HIV) identified as the causative agent, for over 30 years. HIV infection is a significant health problem globally. Earlier diagnosis and initiation of antiretroviral treatment (ART) prevents death, serious sequelae and onward transmission. Mucocutaneous involvement may allow diagnosis at seroconversion or later in the course of the disease and dermatologists should have a very low threshold for considering the diagnosis and offering HIV testing routinely in many common presenting clinical scenarios. Combined ART has revolutionized treatment, and long‐term survival is the norm. However, there are significant dermatological consequences of HIV treatment including drug reactions/complications and immune reconstitution‐associated disease. Primary skin malignancies are the most frequent non‐AIDS‐defining cancers and oral, anal and genital (e.g. penile) cancers are significantly increased in the HIV‐treated population.

show abstract

HIV and the Skin

Bunker,

Piguet

2024

Rook's Textbook of Dermatology

View full text Add to dashboard Cite

Within 2 years of defining acquired immune deficiency syndrome (AIDS) as a distinctive syndrome in 1981, human immunodeficiency virus (HIV) was identified as the causative agent. Dermatological involvement in AIDS has been appreciated since the disease was first recognised. Mucocutaneous involvement establishes criteria for diagnosis and staging; the prognostic significance of some complications, for example pruritic papular eruption/eosinophilic folliculitis, hairy leukoplakia and Kaposi sarcoma (KS), was well recognised before specific treatments were introduced. The proportion of patients with skin complications and the number of these manifestations in any one patient increase as HIV infection progresses and AIDS develops. The incidence and severity of several common cutaneous diseases (such as mollusca, herpes simplex and seborrhoeic dermatitis) are increased in patients with HIV and this correlates in many instances with the absolute numbers of CD4+ T cells. The effect HIV infection may have on some dermatological conditions such as psoriasis and leprosy is less clear‐cut. The advent of highly active combined antiretroviral therapy (ART) has been incalculably beneficial to patients with HIV, but novel side effects of these drugs (such as lipodystrophy) have emerged, and the skin can be affected by manifestations of the immune reconstitution inflammatory syndrome/immune reconstitution associated disease. The dermatological complications of HIV and AIDS may be distressing to patients and difficult for dermatologists to diagnose and manage. Also, many dermatoses presenting in the population at large need to be regarded as ‘indicator conditions’ to prompt advice about, and initiation of, HIV testing.

show abstract

Facial miliary osteoma in HIV patient

Cited by 4 publications

References 8 publications

Multiple miliary osteoma cutis: a comprehensive review and update of the literature

Multiple miliary osteoma cutis: a comprehensive review and update of the literature

HIVand the Skin

HIV and the Skin

Contact Info

Product

Resources

About